Events
September
2019

IRB Seminar - Katja Fink, PhD, Director, Antibody Research, Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland

Institute for Research in Biomedicine

Date: / -

Katja Fink, PhD

"The human B cell response to dengue virus infection"

Director, Antibody Research, Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.

 

 

Tuesday, June 18, 2019 at 12:00

IRB Conference Room

Institute for Research in Biomedicine (IRB)

Via Vincenzo Vela 6

CH-6500 Bellinzona

Faculties